As patient groups begin to gain access to the corridors of power, the spotlight is falling on their relations with the powerful pharmaceutical industry. In an effort to protect their credibility from a murky sea of rumour and speculation, many patient groups are now trying to negotiate a more transparent and arm’s length relationship with their industry sponsors.
Leave a Reply